FDA’s Promising New Framework for Rare Genetic Diseases
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This JAMA Forum discusses the opportunities and challenges facing US Food and Drug Administration (FDA) new approval paths for individualized therapies to treat rare genetic diseases.
Fields of Study & Subjects
Pharmaceutical Economics and Policy
Biomedical Ethics and Regulation
Pharmaceutical studies and practices
Publication details
- Journal / source
- JAMA Health Forum
- Volume
- 7
- Issue
- 3
- Pages
- e261227–e261227
- Publication date
- 26 March 2026
- Language
- EN